• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

复发性妊娠滋养细胞肿瘤的管理:有哪些方法可以降低复发率?

Management of relapsed gestational trophoblastic neoplasia: What can help to reduce the re-recurrence rate?

机构信息

Department of Gynecology, Obstetrics and Gynecology Hospital, Fudan University, Shanghai, China.

出版信息

J Obstet Gynaecol Res. 2022 Jun;48(6):1451-1457. doi: 10.1111/jog.15228. Epub 2022 Mar 14.

DOI:10.1111/jog.15228
PMID:35289459
Abstract

AIM

To explore the risk factors for re-recurrence in relapsed gestational trophoblastic neoplasia (GTN) and therapeutic approaches to reduce the re-recurrence rate.

METHODS

Data of relapsed GTN treated in the Obstetrics and Gynecology Hospital of Fudan University from January 1, 2015, to December 31, 2020, were reviewed retrospectively. Risk factors associated with re-recurrence were analyzed using Logistic regression analysis.

RESULTS

A total of 39 relapsed GTN patients were included in our study. At the time of the first relapse, 14 patients received single-agent chemotherapy and 25 patients received multi-agent chemotherapy. Surgery was performed in 19 patients. Complete remission was achieved in all of the patients. Re-recurrence occurred in 21 patients. Univariate analysis suggested that unifocal recurrence was the only factor significantly associated with re-recurrence (OR = 0.25, p = 0.04). Recurrence pattern-based subgroup analysis showed that the proportion of re-recurrence was lower in patients who received both surgery and chemotherapy compared to those who received only chemotherapy in the unifocal recurrence group (3/11 vs. 2/4), but not in the non-unifocal recurrence group (7/8 vs. 9/16). The results of the multivariate analysis showed that there was no significant difference in re-recurrence rates between the surgical approaches and that the non-unifocal recurrence pattern was an independent risk factor for re-recurrence.

CONCLUSIONS

For relapsed GTN with unifocal recurrence pattern, surgical removal of the lesion can effectively reduce the re-recurrence rate.

摘要

目的

探讨复发性妊娠滋养细胞肿瘤(GTN)的再复发风险因素及降低再复发率的治疗方法。

方法

回顾性分析复旦大学附属妇产科医院 2015 年 1 月 1 日至 2020 年 12 月 31 日收治的复发性 GTN 患者的临床资料,采用 Logistic 回归分析与再复发相关的危险因素。

结果

本研究共纳入 39 例复发性 GTN 患者。在首次复发时,14 例患者接受单药化疗,25 例患者接受多药化疗。19 例患者接受了手术治疗。所有患者均达到完全缓解。21 例患者发生了再复发。单因素分析表明,单病灶复发是唯一与再复发显著相关的因素(OR=0.25,p=0.04)。基于复发模式的亚组分析显示,在单病灶复发组中,接受手术联合化疗的患者再复发比例低于仅接受化疗的患者(3/11 比 2/4),但在多病灶复发组中差异无统计学意义(7/8 比 9/16)。多因素分析结果表明,手术方式对再复发率无显著影响,多病灶复发模式是再复发的独立危险因素。

结论

对于单病灶复发的复发性 GTN,手术切除病灶可有效降低再复发率。

相似文献

1
Management of relapsed gestational trophoblastic neoplasia: What can help to reduce the re-recurrence rate?复发性妊娠滋养细胞肿瘤的管理:有哪些方法可以降低复发率?
J Obstet Gynaecol Res. 2022 Jun;48(6):1451-1457. doi: 10.1111/jog.15228. Epub 2022 Mar 14.
2
Analysis of Clinical Characteristics and Outcomes in 7 Patients with Re-recurrent Gestational Trophoblastic Neoplasia.
J Reprod Med. 2016 Sep;61(9-10):494-502.
3
Outcomes for relapsed versus resistant low risk gestational trophoblastic neoplasia following single-agent chemotherapy.单药化疗后复发与耐药低风险妊娠滋养细胞肿瘤的结局。
Gynecol Oncol. 2020 Dec;159(3):751-757. doi: 10.1016/j.ygyno.2020.09.046. Epub 2020 Oct 3.
4
Prognosis of patients with relapsed and chemoresistant gestational trophoblastic neoplasia transferred to the Peking Union Medical College Hospital.复发和化疗耐药性妊娠滋养细胞肿瘤患者转至北京协和医院的预后。
BJOG. 2010 Jan;117(1):47-52. doi: 10.1111/j.1471-0528.2009.02420.x.
5
[Clinical analysis of patients with relapsed and chemo-resistant gestational trophoblastic neoplasia].复发性及化疗耐药性妊娠滋养细胞肿瘤患者的临床分析
Zhonghua Fu Chan Ke Za Zhi. 2010 Nov;45(11):804-7.
6
Management and risk factors of recurrent gestational trophoblastic neoplasia: An update from 2004 to 2017.复发性妊娠滋养细胞肿瘤的管理与风险因素:2004年至2017年的最新进展
Cancer Med. 2020 Apr;9(7):2590-2599. doi: 10.1002/cam4.2901. Epub 2020 Feb 5.
7
[EMA/CO regimen for chemotherapy 24 patients with ultra high-risk gestational trophoblastic neoplasia].[EMA/CO化疗方案治疗24例超高危妊娠滋养细胞肿瘤]
Zhonghua Fu Chan Ke Za Zhi. 2018 Jun 25;53(6):371-376. doi: 10.3760/cma.j.issn.0529-567x.2018.06.003.
8
Treatment of extremely high risk and resistant gestational trophoblastic neoplasia patients in King Chulalongkorn Memorial Hospital.朱拉隆功国王纪念医院对极高风险及耐药性妊娠滋养细胞肿瘤患者的治疗。
Asian Pac J Cancer Prev. 2014;15(2):925-8. doi: 10.7314/apjcp.2014.15.2.925.
9
Salvage combination chemotherapy with floxuridine, dactinomycin, etoposide, and vincristine (FAEV) for patients with relapsed/chemoresistant gestational trophoblastic neoplasia.对于复发/耐药性妊娠滋养细胞肿瘤患者,采用氟尿嘧啶、放线菌素 D、依托泊苷和长春新碱(FAEV)进行挽救性联合化疗。
Ann Oncol. 2011 Jul;22(7):1588-1594. doi: 10.1093/annonc/mdq649. Epub 2011 Jan 13.
10
Clinical characteristics and prognosis of ultra high-risk gestational trophoblastic neoplasia patients: A retrospective cohort study.超高危妊娠滋养细胞肿瘤患者的临床特征和预后:一项回顾性队列研究。
Gynecol Oncol. 2017 Jul;146(1):81-86. doi: 10.1016/j.ygyno.2017.04.010. Epub 2017 Apr 29.